ATE54757T1 - Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera. - Google Patents

Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.

Info

Publication number
ATE54757T1
ATE54757T1 AT86300600T AT86300600T ATE54757T1 AT E54757 T1 ATE54757 T1 AT E54757T1 AT 86300600 T AT86300600 T AT 86300600T AT 86300600 T AT86300600 T AT 86300600T AT E54757 T1 ATE54757 T1 AT E54757T1
Authority
AT
Austria
Prior art keywords
sera
iii
procedure
htlv
neutralizing antibodies
Prior art date
Application number
AT86300600T
Other languages
English (en)
Inventor
Marjorie Robert Guroff
Robert Charles Gallo
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Application granted granted Critical
Publication of ATE54757T1 publication Critical patent/ATE54757T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
AT86300600T 1985-02-05 1986-01-29 Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera. ATE54757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69858885A 1985-02-05 1985-02-05
EP86300600A EP0193284B1 (de) 1985-02-05 1986-01-29 Verfahren zum Nachweis von HTLV-III neutralisierenden Antikörpern in Sera

Publications (1)

Publication Number Publication Date
ATE54757T1 true ATE54757T1 (de) 1990-08-15

Family

ID=24805871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86300600T ATE54757T1 (de) 1985-02-05 1986-01-29 Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.

Country Status (9)

Country Link
EP (1) EP0193284B1 (de)
JP (1) JPS61502910A (de)
AT (1) ATE54757T1 (de)
AU (1) AU577937B2 (de)
CA (1) CA1271417A (de)
DE (1) DE3672624D1 (de)
IE (1) IE860315L (de)
NZ (1) NZ214979A (de)
WO (1) WO1986004613A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
ATE151638T1 (de) 1987-02-20 1997-05-15 Genentech Inc Verfahren und zubereitungen für die verwendung von hiv-env-polypeptiden und antikörpern
FR2615623B1 (fr) * 1987-05-22 1992-06-19 Transgene Sa Test de diagnostic du sida base sur la mise en evidence d'une diversite de la reponse isotypique, vaccins et serotherapies
US6657050B1 (en) * 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
EP0379516B1 (de) * 1987-08-11 1993-10-06 The Regents Of The University Of Minnesota Hyperimmun globulin gegen hiv
EP0356007A3 (de) * 1988-07-22 1991-07-03 Medical Research Council Antigenische Determinanten
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
CN103356636A (zh) 2004-05-23 2013-10-23 杰勒德·M·豪斯 Theramutein调节剂
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7609183A (nl) * 1975-09-04 1977-03-08 Merck & Co Inc Werkwijze voor het bepalen van de infectiviteit van viruspreparaten en werkwijze voor het be- palen van het antilichaamgehalte van serum.
IE58321B1 (en) * 1984-04-23 1993-09-08 Us Health Isolation of proteins of HTLV-III, serological detection of antibodies to HTLV-III in sera of patients with aids and pre-aids conditions, and detection of HTLV-III infection bi/immuno-assays using HTLV-III infection by immuno-assays using HTLV-III and its proteins
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
CA1254118A (en) * 1984-12-28 1989-05-16 The United States Of America, Represented By The Secretary, U.S. Departm Ent Of Commerce In situ detection of human t-cell leukemia virus type iii
BE904030A (fr) * 1985-01-15 1986-07-14 Cancer Res Inst Procede de recherche d'anticorps et equipement ou kit pour la mise en oeuvre de ce procede.

Also Published As

Publication number Publication date
CA1271417A (en) 1990-07-10
DE3672624D1 (de) 1990-08-23
IE860315L (en) 1986-08-05
AU5454586A (en) 1986-08-26
NZ214979A (en) 1988-05-30
JPS61502910A (ja) 1986-12-11
WO1986004613A1 (en) 1986-08-14
EP0193284A1 (de) 1986-09-03
AU577937B2 (en) 1988-10-06
EP0193284B1 (de) 1990-07-18

Similar Documents

Publication Publication Date Title
ZA853025B (en) Isolation of proteins of htlv-iii,serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions,and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins
EP0181374A4 (de) Isolierung von htlv-iii-proteinen, serologische bestimmung von htlv-iii-antikörpern in sera von patienten mit aids und prä-aids-zuständen und bestimmung von htlv-iii-infektion mittels immunotestverfahren unter verwendung von htlv-iii und seinen proteinen.
DE3876496D1 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
DK0891982T3 (da) HIV-peptider
DK0386882T3 (da) Pakningsdefekt HIV-provirus, cellelinier og anvendelse heraf
ATE54757T1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
GB2154609B (en) Hcmv monoclonal antibodies and their use in the detection of hcmv infection and hcmv specific igm, and methods of detecting viral antigens
DE3650019T2 (de) Expression von Virusproteinen mit immunologischer Aktivität.
DE69013950T2 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
SE8203909L (sv) Bestemning av virus kenslighet for antivirala medel
Levitt et al. Solid-Phase Radioimmunossay for Rapid Detection and Identification of Western Equine Encephalomyelitis Virus
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
SU1533329A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита
UA8704A1 (uk) Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу
EP0365172A3 (de) Nachweis von anti-pre-S-Antikörpern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee